Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19 is a research paper published in Journal of General Internal Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 26 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
national institute of general medical sciences
Grant: P20GM125507
national institute of general medical sciences
Grant: U54GM115677
national institute on drug abuse
Grant: K23DA042140
substance abuse and mental health services administration
Grant: Grant to Address Mental
substance abuse and mental health services administration
Grant: Substance Use Disorders During COVID-19
centers for disease control and prevention
Grant: Overdose Data to Action
National Institutes of Health
Grant: 5P20GM125507-03
COBRE Center on Opioids and Overdose
National Institutes of Health
Grant: 3U54GM115677-05S1
Rhode Island Center for Clinical and Translational Science
National Institutes of Health
Grant: 5K23DA042140-05
Development of a text messaging tool to support buprenorphine treatment in primary care
FWCI
5.04
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals